ArticleScientific reports2025

Plasma S100A8/A9 level predicts response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer.

Tadahiro Kuribayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.